{"id":24567,"date":"2022-04-01T08:25:00","date_gmt":"2022-04-01T12:25:00","guid":{"rendered":"https:\/\/www.diabete.qc.ca\/en\/news\/attention-vous-utilisez-novorapid-humalog-ou-lantus-la-transition-aux-biosimilaires-sen-vient\/"},"modified":"2023-05-30T14:17:09","modified_gmt":"2023-05-30T18:17:09","slug":"are-you-using-novorapid-humalog-or-lantus-the-transition-to-biosimilars-is-upon-us","status":"publish","type":"post","link":"https:\/\/www.diabete.qc.ca\/en\/news\/are-you-using-novorapid-humalog-or-lantus-the-transition-to-biosimilars-is-upon-us\/","title":{"rendered":"Are you using NOVORAPID, HUMALOG, or LANTUS? The transition to biosimilars is upon us!"},"content":{"rendered":"\n

As of April 13 (Lantus and Humalog) and July 6, 2022 (Novorapid), the R\u00e9gie de l’assurance maladie du Qu\u00e9bec (RAMQ) will stop covering these insulins. The corresponding biosimilar insulins will now be reimbursed.<\/p>\n\n\n\n

What is a biosimilar?<\/strong><\/h2>\n\n\n\n

A biosimilar is a very similar copy of a biologic drug. A biologic drug is produced from living cells, as in the case of insulin. Biosimilars are used to treat diseases such as arthritis, ulcerative colitis, Crohn’s disease, cancer, psoriasis and diabetes. Biosimilars are safe and effective. They are approved by Health Canada and evaluated by the Institut national d’excellence en sant\u00e9 et en services sociaux (INESSS) before being registered on the list of medications of the R\u00e9gie d’assurance maladie du Qu\u00e9bec (RAMQ).<\/p>\n\n\n\n

To learn more about biosimilars, click HERE.<\/a><\/p>\n\n\n\n

To learn all about the transition from biologics to biosimilars, <\/strong>read the article<\/strong><\/a> (in French only) <\/a>by our pharmacist colleague Alexandre Chadi.<\/strong><\/p>\n\n\n\n

Insuline glargine <\/strong>(Lantus\u00ae<\/sup> \u2192 Basaglar\u00ae<\/sup>)<\/h2>\n\n\n\n

Since 2017, all patients starting a new insulin glargine treatment are required to use the biosimilar Basaglar\u00ae<\/sup>, whose reference drug is Lantus\u00ae.<\/sup> For those currently using Lantus\u00ae<\/sup>, the deadline to make the change is April 13, 2022<\/strong>, with some exceptions.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Insuline lispro<\/strong> (Humalog\u00ae<\/sup> \u2192 Admelog\u00ae<\/sup>)<\/h2>\n\n\n\n

Since March 2021, all patients starting a new insulin lispro treatment are required to use the biosimilar Admelog\u00ae<\/sup>, whose reference drug is Humalog\u00ae.<\/sup> For people currently using Humalog\u00ae<\/sup>, the deadline to make the change is April 13, 2022<\/strong>, with some exceptions.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Insuline asparte<\/strong> (NovoRapidMD<\/sup> \u2192 TrurapiMC<\/sup>)<\/h2>\n\n\n\n

As of February 2, 2022, all patients starting a new insulin aspart treatment must use the biosimilar Trurapi\u2122<\/sup>, whose reference drug is NovoRapid\u00ae.<\/sup> For people currently using the NovoRapid\u00ae<\/sup>, the deadline to make the change is July 6, 2022,<\/strong> with some exceptions.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

What steps do I need to take?<\/strong><\/h2>\n\n\n\n

If you have not yet made the transition to a biosimilar, check with your prescriber (doctor, specialized nurse practitioner) or pharmacist as soon as possible to ensure you get a new prescription and the appropriate injector pen before <\/strong>April 13 or July 6, 2022, depending on your situation.<\/p>\n\n\n\n

To read the notice (in French only) issued by the RAMQ, click HERE<\/a><\/p>\n\n\n\n

To learn more about exceptions, click HERE<\/a><\/p>\n\n\n\n

<\/div>\n\n\n\n

Research and writing :<\/strong> Diabetes Qu\u00e9bec team of health profesionals<\/p>\n\n\n\n

\u00a9 Diabetes Qu\u00e9bec \u2013 February 2022<\/p>\n","protected":false},"excerpt":{"rendered":"

As of April 13 (Lantus and Humalog) and July 6, 2022 (Novorapid), the R\u00e9gie de l’assurance maladie du Qu\u00e9bec (RAMQ) will stop covering these insulins. The corresponding biosimilar insulins will now be reimbursed. What is a biosimilar? A biosimilar is a very similar copy of a biologic drug. A biologic drug is produced from living…<\/p>\n","protected":false},"author":1,"featured_media":17160,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"24593,194,24595,24586,24576,24579","_relevanssi_noindex_reason":"","footnotes":""},"categories":[151],"tags":[],"class_list":["post-24567","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/posts\/24567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/comments?post=24567"}],"version-history":[{"count":3,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/posts\/24567\/revisions"}],"predecessor-version":[{"id":27351,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/posts\/24567\/revisions\/27351"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/media\/17160"}],"wp:attachment":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/media?parent=24567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/categories?post=24567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/tags?post=24567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}